Evaluation and management of patients with heart disease and cancer: cardio-oncology.

Evaluation and management of patients with heart disease and cancer: cardio-oncology.
复制标题

DOI:
10.1016/j.mayocp.2014.05.013
复制
发表时间:
2014-09
影响因子:
8.9
通讯作者:
Kohli M
Kohli M
中科院分区:
医学2区
文献类型:
--
作者:
Herrmann J;Lerman A;Sandhu NP;Villarraga HR;Mulvagh SL;Kohli M

文献摘要

参考文献

被引文献

相似文献

在过去的几十年里,对癌症患者的护理有了很大的进步。早期癌症诊断和更多地使用传统和新型系统治疗相结合,降低了癌症相关死亡率。然而,有效的癌症治疗可能导致短期和长期合并症,这可能通过影响生活质量和生存率来降低净临床收益。特别是,癌症治疗的心血管并发症可能对癌症患者的健康产生深远的影响,并且在患有公认或未被公认的潜在心血管疾病的患者中更常见。因此,一个新的学科称为“心血管肿瘤学”,以解决癌症患者的心血管需求,并优化他们的护理在多学科的方法。本文简要介绍了这一新兴领域的背景知识,重点介绍了其在癌症治疗前的心血管风险评估和预防、癌症治疗期间的心血管监测和治疗以及癌症治疗后的心血管监测和管理等方面的应用。本综述的内容基于1960年1月1日至2014年2月1日期间PubMed的文献检索,检索词为癌症、心肌病、心脏毒性、心脏肿瘤学、化疗、心力衰竭和放疗。
The care for patients with cancer has advanced greatly over the past decades. A combination of earlier cancer diagnosis and greater use of traditional and novel systemic treatments has decreased cancer-related mortality. Effective cancer therapies, however, can result in short- and long-term co-morbidities that can decrease the net clinical gain by impacting quality of life and survival. In particular, cardiovascular complications of cancer treatments can have a profound impact on the health of cancer patients and are more common among those with recognized or unrecognized underlying cardiovascular diseases. A new discipline termed “cardio-oncology” has thus evolved to address the cardiovascular needs of cancer patients and optimize their care in a multidisciplinary approach. This review provides a brief introduction and background on this emerging field and then focuses on its practical aspects including: cardiovascular risk assessment and prevention before cancer treatment, cardiovascular surveillance and therapy during cancer treatment, and cardiovascular monitoring and management after cancer therapy. The content of this review is based on a literature search of PubMed between January 1, 1960, and February 1, 2014 using the search terms cancer, cardiomyopathy, cardiotoxicity, cardio-oncology, chemotherapy, heart failure, and radiation.
DOI: 10.1007/s10565-006-0140-y
发表时间: 2007-01-01
影响因子: 6.1
作者:
Berthiaume, J. M.;Wallace, K. B.
通讯作者: Wallace, K. B.
DOI: 10.1056/nejmoa1209825
发表时间: 2013-03-14
影响因子: 158.5
作者:
Darby, Sarah C.;Ewertz, Marianne;Hall, Per
通讯作者: Hall, Per
DOI: 10.1016/j.ophtha.2012.02.010
发表时间: 2012-08-01
期刊: OPHTHALMOLOGY
影响因子: 13.7
作者:
Do, Diana V.;Quan Dong Nguyen;Heier, Jeff S.
通讯作者: Heier, Jeff S.
DOI: 10.1016/s0735-1097(00)00748-8
发表时间: 2000-08-01
影响因子: 24
作者:
Cardinale, D;Sandri, MT;Fiorentini, C
通讯作者: Fiorentini, C
DOI: 10.1200/jco.2009.27.3615
发表时间: 2010-09-01
影响因子: 45.3
作者:
Cardinale, Daniela;Colombo, Alessandro;Cipolla, Carlo M.
通讯作者: Cipolla, Carlo M.